Translational Digital Pathology and AI Summit on April 16-18, 2024 in Boston, United States

There has been incredible innovation, collaboration, and investment in the translational digital pathology space. Yet, to date, there have been no dedicated conferences promising to successfully address the critical bottlenecks and exciting developments occurring from the perspective of the biopharma community. From tackling fundamental validation steps, to unequivocal advances in image analysis and AI applications, to overcoming regulatory challenges, this summit will be a game changer, facilitating unparalleled networking, thought-provoking discussions and innovative strategies to shape this ever-growing field.

Within this context, the Translational Digital Pathology and AI Summit will premiere for the first time to host the most comprehensive, ultra-specialized, industry dedicated meeting, to unite over 60 experts to explore new data and strategies to fast-track the adoption, standardization and limitless potential of digital pathology and AI.

URLs:

Tickets: https://go.evvnt.com/2174328-0?pid=10008

Brochure: https://go.evvnt.com/2174328-3?pid=10008

Time: 2:00 pm - 4:45 pm

Prices:

Conference + Focus Day - Drug Developer Pricing: USD 3598.00,

Conference Only - Drug Developer Pricing: USD 2999.00,

Conference + Focus Day - Solution Provider Pricing: USD 4398.00,

Conference Only - Solution Provider Pricing: USD 3699.00,

Conference + Focus Day - Academic Pricing: USD 3098.00,

Conference Only - Academic Pricing: USD 2599.00

Speakers: Christopher Garcia, Medical Director, Computational Pathology and AI - Mayo Clinic, Claudia Dollins, Vice President, Precision Medicines, Global Regulatory Affairs - GlaxoSmithKline Plc, Edwin Roger Parra Cuentas, Associate Professor - University Texas MD Anderson Center, Erik Hagendorn, Principal Scientist - Abbvie, Heike Fuhrmann-Stroissnigg, Director - Rubedo Life Sciences Inc, Huw Bannister, Senior Director of Digital and Computational Pathology, Global Diagnostics - AstraZeneca, Iman Tavassoly, Director - Quantitative Pharmacology - Repare Therapeutics, Jessica Baumann, Director of Pathology Diagnostics, Scientific Affairs, Global Oncology Diagnostics - AstraZeneca, Jimmy Tran, Associate Scientific Director - Pathology, Nonclinical Safety - Biogen, Kuldeep Singh, Senior Director, Head of Pathology, Preclinical Development - Wave Life Sciences, Lauri Diehl, Executive Director - Research Pathology and Pathologist - Gilead Sciences, Luis Cano Ayestas, Pathologist in Precision Medicine and Computational Biology - Sanofi, Meijian Guan, Associate Director - Translational Data Science - Genmab, Sabya Biswas, Senior Scientist - Abbvie, Sarah Vargas, Image Analysis and Electron Microscopy Scientist - Pfizer, Zoltan Laszik, Professor of Pathology - Director of Digital Pathology - UCSF